Evidence map›Paper›PMID 33689457›Full record

ArticleAIDS patient care and STDs2021

Viral Suppression Is Associated with HIV Treatment Self-Efficacy in a Cohort of Women in Washington, DC.

Amanda Blair Spence, Katherine Michel, Cuiwei Wang, Mary Ann Dutton, Kathryn Lee, Daniel Merenstein, Lucile Adams-Campbell, Katheryn Bell, Anjali Kikkisetti, Allison Doyle and 3 more

Abstract read
In one paragraph

Article in AIDS patient care and STDs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Amanda Blair SpenceDivision of Infectious Disease, Georgetown University Medical Center, Washington, District of Columbia, USA.
Katherine MichelDivision of Infectious Disease, Georgetown University Medical Center, Washington, District of Columbia, USA.
Cuiwei WangDivision of Infectious Disease, Georgetown University Medical Center, Washington, District of Columbia, USA.
Mary Ann DuttonDepartment of Psychiatry, Georgetown University Medical Center, Washington, District of Columbia, USA.
Kathryn LeeSchool of Medicine, Georgetown University, Washington, District of Columbia, USA.
Daniel MerensteinDepartment of Family Medicine, Georgetown University Medical Center, Washington, District of Columbia, USA.
Lucile Adams-CampbellGeorgetown University Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA.
Katheryn BellDepartment of Psychiatry, Georgetown University Medical Center, Washington, District of Columbia, USA.
Anjali KikkisettiUniversity of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Allison DoyleSchool of Medicine, Georgetown University, Washington, District of Columbia, USA.
Mikayla CochraneBucknell University, Lewisburg, Pennsylvania, USA.
Lakshmi GoparajuDivision of Infectious Disease, Georgetown University Medical Center, Washington, District of Columbia, USA.
Seble KassayeDivision of Infectious Disease, Georgetown University Medical Center, Washington, District of Columbia, USA.

Funding

WOMEN'S INTERAGENCY HIV STUDY (WIHS) ORGANIZATION AND MANAGEMENTU01AI034994 · NIAID · GEORGETOWN UNIVERSITY · PI KASSAYE, SEBLE G · 1993 to 2018
$52.0M
Surviving the HIV Epidemic (S/HE) in metropolitan Washington DC - Advancing knowledge through cohort studiesU01HL146205 · NHLBI · GEORGETOWN UNIVERSITY · PI SEBLE G KASSAYE, DANIEL J MERENSTEIN · 2019 to 2026
$23.5M
Institutional Career Development CoreKL2TR001432 · NCATS · GEORGETOWN UNIVERSITY · PI UMANS, JASON G · 2015 to 2024
$7.5M
NCATS NIH HHS KL2 TR001432NHLBI NIH HHS U01 HL146205NIAID NIH HHS U01 AI034994
6 · The paper itself

Abstract

The goal of HIV treatment is viral suppression as it is linked with improved health outcomes and decreased risk of viral transmission. We assessed the sociodemographic, behavioral, and patient-provider interaction associations with viral suppression with an administered survey to HIV-seropositive women in the metropolitan Washington, DC, site of the Women's Interagency HIV Study (WIHS) between 2017 and 2018. Logistic and mixed models were used to explore related factors between HIV viral suppression groups and HIV treatment self-efficacy, respectively. Higher HIV treatment self-efficacy and disclosure concerns were positively associated with viral suppression, while illicit drug use had a negative association. In mixed models, more health care provider trust was associated with higher HIV treatment self-efficacy, while depressive symptoms were associated with lower HIV treatment self-efficacy. Depression, illicit substance use, and HIV treatment self-efficacy are potentially modifiable factors that can influence viral suppression. Implementation studies are needed to determine whether interventions to manage depression or self-efficacy and improve trust in health care providers will influence treatment outcomes.

Indexed as

HIV InfectionsSelf EfficacyCohort StudiesDistrict of ColumbiaFemaleHumansTreatment OutcomeViral LoaddepressionHIV treatment adherenceHIV treatment self-efficacyviral suppression

Identifiers

PMID33689457
PMCPMC7987352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.